Common Sense Oncology shared on LinkedIn:
“Join us for a special CSO webinar featuring the Principal Investigators of the SONIA Trial, Professor Gabe Sonke and Dr. Annemiek van Ommen – Nijhof along with CSO Leaders Professor Winette van der Graaf, Dr. Bishal Gyawali, and Professor Ian Tannock.
We will explore the results of the trial looking at CDK4/6 inhibitors in first- or second-line treatment of advanced breast cancer, and its implications for policy, de-escalation trial design, trial funding, financial toxicity, quality-of-life, and more.
We invite you to join in on the discussion and ask any questions to our expert lineup.
Date: Tuesday, May 13, 2025 at 2:00 pm EDT (8:00 pm CEST)
Platform: Zoom
Register.”